Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12323/4681
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAdli, Hawa-
dc.date.accessioned2020-08-19T14:13:12Z-
dc.date.available2020-08-19T14:13:12Z-
dc.date.issued2020-
dc.identifier.citationKhazar Journal of Science and Technologyen_US
dc.identifier.issn2520-6133-
dc.identifier.urihttp://hdl.handle.net/20.500.12323/4681-
dc.description.abstractThe aim of this review was to summarize data from studies making inquiries on levels of the cytokines in pathogenesis of peri-implant diseases. Here we reviewed the recent developments on IL-1β, IL-10, IL-17, IL-21, and IL-33. We highlighted recent advances during the last few years in this area and discussed their roles in immune regulation in patients with peri-implant disease.Our results revealed that identifying the levels of these cytokines (IL-1β, IL-10, IL-17, IL-21, and IL-33) may help to predict the diagnosis of periimplant diseases. From a safety perspective, this study emphasized the need to consider the impact of these interleukin on peri-implant diseases.en_US
dc.language.isoenen_US
dc.publisherKhazar University Pressen_US
dc.relation.ispartofseriesVol. 4;№ 1-
dc.subjectPeri-implant diseasesen_US
dc.subjectcytokinesen_US
dc.subjectinterleukins Introductionen_US
dc.titleCytokines and Peri-Implant Diseaseen_US
dc.typeArticleen_US
Appears in Collections:2020, Vol. 4, № 1

Files in This Item:
File Description SizeFormat 
Cytokines and Peri-Implant Disease.pdf162.04 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.